Deltex Medical Group Stock Current Valuation
| DEMG Stock | 0.08 0.01 6.67% |
Valuation analysis of Deltex Medical Group helps investors to measure Deltex Medical's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At this time, Deltex Medical's Cash is comparatively stable compared to the past year. Cash And Short Term Investments is likely to gain to about 920.5 K in 2024, despite the fact that Other Cashflows From Financing Activities is likely to grow to (232.8 K). Fundamental drivers impacting Deltex Medical's valuation include:
Price Book 0.535 | Enterprise Value 3.2 M | Enterprise Value Ebitda (11.45) | Price Sales 0.8517 | Forward PE 21.645 |
Overvalued
Today
Please note that Deltex Medical's price fluctuation is out of control at this time. Calculation of the real value of Deltex Medical Group is based on 3 months time horizon. Increasing Deltex Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Deltex stock is determined by what a typical buyer is willing to pay for full or partial control of Deltex Medical Group. Since Deltex Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Deltex Stock. However, Deltex Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.08 | Real 0.0767 | Hype 0.08 | Naive 0.0871 |
The intrinsic value of Deltex Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Deltex Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Deltex Medical Group helps investors to forecast how Deltex stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Deltex Medical more accurately as focusing exclusively on Deltex Medical's fundamentals will not take into account other important factors: Deltex Medical Group Company Current Valuation Analysis
Deltex Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Deltex Medical Current Valuation | 3.17 M |
Most of Deltex Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Deltex Medical Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Deltex Medical Group has a Current Valuation of 3.17 M. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The current valuation for all United Kingdom stocks is notably lower than that of the firm.
Deltex Medical Group is rated as one of the top companies in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about 6.35 Million. Deltex Medical totals roughly 3.17 Million in current valuation claiming about 50% of equities under Health Care industry.Deltex Fundamentals
| Return On Equity | -0.57 | ||||
| Return On Asset | -0.0777 | ||||
| Profit Margin | (0.72) % | ||||
| Operating Margin | (0.42) % | ||||
| Current Valuation | 3.17 M | ||||
| Shares Outstanding | 1.9 B | ||||
| Shares Owned By Insiders | 67.69 % | ||||
| Shares Owned By Institutions | 18.91 % | ||||
| Price To Book | 0.54 X | ||||
| Price To Sales | 0.85 X | ||||
| Revenue | 1.78 M | ||||
| Gross Profit | 1.84 M | ||||
| EBITDA | (1 M) | ||||
| Net Income | (1.26 M) | ||||
| Total Debt | 1.92 M | ||||
| Book Value Per Share | 0 X | ||||
| Cash Flow From Operations | (1.2 M) | ||||
| Target Price | 8.0 | ||||
| Number Of Employees | 24 | ||||
| Beta | 0.82 | ||||
| Market Capitalization | 1.52 M | ||||
| Total Asset | 5.93 M | ||||
| Retained Earnings | (57.77 M) | ||||
| Working Capital | 835 K | ||||
| Net Asset | 5.93 M |
About Deltex Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Deltex Medical Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Deltex Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Deltex Medical Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Deltex Stock Analysis
When running Deltex Medical's price analysis, check to measure Deltex Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Deltex Medical is operating at the current time. Most of Deltex Medical's value examination focuses on studying past and present price action to predict the probability of Deltex Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Deltex Medical's price. Additionally, you may evaluate how the addition of Deltex Medical to your portfolios can decrease your overall portfolio volatility.